Menu Search
Equities

Varex Imaging Corp

VREX:NSQ

Varex Imaging Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)14.22
  • Today's Change-0.05 / -0.35%
  • Shares traded594.33k
  • 1 Year change-23.22%
  • Beta0.5523
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Varex Imaging Corp grew net income 59.08% from 30.30m to 48.20m primarily through revenue growth (859.40m to 893.40m). For while the costs associated with cost of goods, selling, general and administrative and debt all increased as a percentage of sales, the 3.96% growth in revenues contributed enough to still see net income improve.
Gross margin32.16%
Net profit margin4.17%
Operating margin3.49%
Return on assets2.82%
Return on equity6.15%
Return on investment3.33%
More ▼

Cash flow in USDView more

In 2023, Varex Imaging Corp increased its cash reserves by 69.98%, or 63.40m. The company earned 108.40m from its operations for a Cash Flow Margin of 12.13%. In addition the company used 44.90m on investing activities and also paid 200.00k in financing cash flows.
Cash flow per share1.34
Price/Cash flow per share8.55
Book value per share14.22
Tangible book value per share6.75
More ▼

Balance sheet in USDView more

Varex Imaging Corp has a Debt to Total Capital ratio of 42.71%, a lower figure than the previous year's 83.01%.
Current ratio3.34
Quick ratio1.89
Total debt/total equity0.7636
Total debt/total capital0.4271
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 31.56%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
EPS growth(5 years)12.63
EPS (TTM) vs
TTM 1 year ago		-32.74
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.